BioCatalyst

MLTX — MoonLake Immunotherapeutics catalysts

1 verified catalyst event(s) for MoonLake Immunotherapeutics (ticker MLTX). Each is linked to its official source. Verified as of 2026-11-04.

Next verified catalyst

2027-01-04 — Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadeq · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-01-04
in 2mo
ESTIMATED
 READOUT
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-T
Phase 3 · Arthritis, Psoriatic
 MLTX MoonLake Immunotherapeutics Sonelokimab, Risankizumab ClinicalTrials.gov ↗
✓ Source-checked 2026-11-04
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.